EUVIMEDEUVIMED entdecken
Multizentrische Studie

Laser in situ fenestrated endograft (LIFE) repair of complex aortic arch pathology: Early outcomes from the multicenter LIFE registry

Brant W Ullery, Fanny Alie-Cusson, Gregory A Magee, Sukgu M Han, Jordan R Stern, Andrew Barleben, Jeromy S Brink, Robert Allen, Mark Fugate, Kenneth Tran, Jason T Lee, Frank R Arko und 2 weitere

Journal of Vascular Surgery · 2026

DOI: 10.1016/j.jvs.2025.09.056 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Vascular Surgery, 2026. Verfasst von Brant W Ullery und 13 weiteren Autor:innen. Beteiligte Einrichtung: Oregon Vascular Specialists, Portland, OR; Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence Heart Institute, Provid…. Hauptthemen laut MEDLINE: Endovascular Procedures, Aorta, Thoracic, Blood Vessel Prosthesis Implantation, Blood Vessel Prosthesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Medtronic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Endovascular repair of aortic arch pathologies is limited by currently available device configurations, variation in aortic arch anatomy, access challenges, and frequent nonelective surgical acuity. The present study aims to assess the feasibility and midterm outcomes of laser in situ fenestrated endograft (LIFE) repair for supra-aortic arch branches during thoracic endovascular repair (TEVAR). METHODS: Patients who underwent LIFE during TEVAR for aortic arch pathologies (2017-2022) were retrospectively identified at six high-volume centers, and data were collected in the multicenter LIFE registry. Descriptive statistics and Kaplan-Meier analysis were used. Primary outcomes were technical success, stroke, and target vessel instability. Secondary outcomes included 30-day mortality, spinal cord ischemia, and reinterventions. RESULTS: A total of 82 patients who underwent LIFE with supra-aortic arch involvement were included. The mean age was 62.4 years (29.3% female and 78.0% White). Select demographics of the cohort featured previous stroke in 17.1% of cases, chronic lung disease in 12.2%, and renal insufficiency in 30.5%. Indication(s) for TEVAR included type B aortic dissection in 70.7% of cases, aneurysm in 11.0%, and penetrating atherosclerotic ulcer/intramural hematoma in 4.9%. Repair was performed for nonelective pathologies in 47.9% of cases. Eighty-nine supra-aortic arch branch vessels (innominate, n = 6; left common carotid artery, n = 9; and left subclavian artery, n = 74) were incorporated via LIFE to achieve proximal seal in zone 0 (19%), zone 1 (5%), and zone 2 (75%). LIFE repair was performed for a single-branch vessel in 90% of cases and a double-branch vessel in 10%. Ten patients underwent adjunctive extra-anatomic bypass. Technical success was achieved in 95.1% of cases. Thirty-day mortality was 2.4% (n = 2). Early (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endovascular ProceduresAorta, ThoracicBlood Vessel Prosthesis ImplantationBlood Vessel ProsthesisAortic DiseasesAortic Aneurysm, ThoracicLaser TherapyHumansFemaleMaleRegistriesRetrospective StudiesMiddle AgedAgedTreatment OutcomeTime FactorsProsthesis DesignPostoperative ComplicationsRisk FactorsFeasibility StudiesStents

Stichwörter der Autor:innen

Aortic archAortic diseaseIn situ fenestrationTEVARThoracic aorta

Autor:innen und Institutionen

  • Oregon Vascular Specialists, Portland, OR; Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence Heart Institute, Providence Research Network, Portland, OR. Electronic address: brantullery@o…
  • Division of Vascular Surgery, Atrium Health, Charlotte, NC.
  • Division of Vascular Surgery, New York University, New York, NY.
  • Division of Vascular Surgery, University of Southern California, Los Angeles, CA.
  • Division of Vascular Surgery, Weill Cornell Medical College, New York, NY.
  • Division of Vascular Surgery, University of California Davis, Sacramento, CA.

Förderung

  • Medtronic

Zitieren

APA

Ullery, B. W., Alie-Cusson, F., Magee, G. A., Han, S. M., Stern, J. R., Barleben, A., Brink, J. S., Allen, R., Fugate, M., Tran, K., Lee, J. T., Arko, F. R., Schlesselman, C., & Bath, J. M. (2026). Laser in situ fenestrated endograft (LIFE) repair of complex aortic arch pathology: Early outcomes from the multicenter LIFE registry. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.09.056

Vancouver

Ullery BW, Alie-Cusson F, Magee GA, Han SM, Stern JR, Barleben A, et al. Laser in situ fenestrated endograft (LIFE) repair of complex aortic arch pathology: Early outcomes from the multicenter LIFE registry. Journal of Vascular Surgery. 2026. doi:10.1016/j.jvs.2025.09.056

BibTeX
@article{Ullery2026,
  author = {Ullery, Brant W and Alie-Cusson, Fanny and Magee, Gregory A and Han, Sukgu M and Stern, Jordan R and Barleben, Andrew and Brink, Jeromy S and Allen, Robert and Fugate, Mark and Tran, Kenneth and Lee, Jason T and Arko, Frank R and Schlesselman, Chase and Bath, Jonathan M},
  title = {Laser in situ fenestrated endograft (LIFE) repair of complex aortic arch pathology: Early outcomes from the multicenter LIFE registry},
  journal = {Journal of Vascular Surgery},
  year = {2026},
  doi = {10.1016/j.jvs.2025.09.056}
}
Kostenlos starten →